Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-262013
Filing Date
2017-08-18
Accepted
2017-08-18 14:07:07
Documents
5
Period of Report
2017-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d422694d6k.htm 6-K 10898
2 EX-99.1 d422694dex991.htm EX-99.1 177282
3 EX-99.2 d422694dex992.htm EX-99.2 90217
4 EX-99.3 d422694dex993.htm EX-99.3 69942
5 GRAPHIC g422694img1.jpg GRAPHIC 12361
  Complete submission text file 0001193125-17-262013.txt   366471
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 171040794
SIC: 2834 Pharmaceutical Preparations